DRUG BINDING INTERFACES MAPPED TO '2hyy'

List of Binding Interfaces
(Click on the entry ID to view details of interfaces and pattern clusters)
(Note that ASSAM search use only 3-12 residue containing patterns)

Filter list by:

DrReposER ID	PDB	Ligand	Organism	Macromolecule	Pfam	Res.	Interface	HETATM
2HYY_A_STIA600	2hyy	STI DB00619 (Imatinib)	Homo sapiens	PROTO-ONCOGENE TYROSINE-PROTEIN KINASE ABL1	PF07714 (Pkinase_Tyr)	18	LEU A 248 TYR A 253 VAL A 256 ALA A 269 LYS A 271 GLU A 286 VAL A 289 MET A 290 ILE A 293 VAL A 299 ILE A 313 THR A 315 PHE A 317 GLY A 321 ARG A 362 LEU A 370 ALA A 380 ASP A 381	STI A 600
2HYY_B_STIB600	2hyy	STI DB00619 (Imatinib)	Homo sapiens	PROTO-ONCOGENE TYROSINE-PROTEIN KINASE ABL1	no annotation	18	LEU B 248 TYR B 253 VAL B 256 ALA B 269 LYS B 271 GLU B 286 VAL B 289 MET B 290 ILE B 293 VAL B 299 ILE B 313 THR B 315 PHE B 317 MET B 318 GLY B 321 LEU B 370 ALA B 380 ASP B 381	STI B 600
2HYY_C_STIC600	2hyy	STI DB00619 (Imatinib)	Homo sapiens	PROTO-ONCOGENE TYROSINE-PROTEIN KINASE ABL1	no annotation	18	LEU C 248 TYR C 253 VAL C 256 ALA C 269 LYS C 271 GLU C 286 VAL C 289 MET C 290 ILE C 293 VAL C 299 ILE C 313 THR C 315 PHE C 317 MET C 318 GLY C 321 LEU C 370 ALA C 380 ASP C 381	STI C 600
2HYY_D_STID600	2hyy	STI DB00619 (Imatinib)	Homo sapiens	PROTO-ONCOGENE TYROSINE-PROTEIN KINASE ABL1	no annotation	16	LEU D 248 TYR D 253 VAL D 256 ALA D 269 LYS D 271 GLU D 286 MET D 290 ILE D 293 VAL D 299 ILE D 313 THR D 315 PHE D 317 MET D 318 LEU D 370 ALA D 380 ASP D 381	STI D 600

[["2HYY_A_STIA600","2hyy","STI","DB00619(Imatinib)","Homo sapiens","PROTO-ONCOGENE TYROSINE-PROTEIN KINASE ABL1","PF07714(Pkinase_Tyr)",18,"LEU A 248;TYR A 253;VAL A 256;ALA A 269;LYS A 271;GLU A 286;VAL A 289;MET A 290;ILE A 293;VAL A 299;ILE A 313;THR A 315;PHE A 317;GLY A 321;ARG A 362;LEU A 370;ALA A 380;ASP A 381","STI A 600\r"],["2HYY_B_STIB600","2hyy","STI","DB00619(Imatinib)","Homo sapiens","PROTO-ONCOGENE TYROSINE-PROTEIN KINASE ABL1","no annotation",18,"LEU B 248;TYR B 253;VAL B 256;ALA B 269;LYS B 271;GLU B 286;VAL B 289;MET B 290;ILE B 293;VAL B 299;ILE B 313;THR B 315;PHE B 317;MET B 318;GLY B 321;LEU B 370;ALA B 380;ASP B 381","STI B 600\r"],["2HYY_C_STIC600","2hyy","STI","DB00619(Imatinib)","Homo sapiens","PROTO-ONCOGENE TYROSINE-PROTEIN KINASE ABL1","no annotation",18,"LEU C 248;TYR C 253;VAL C 256;ALA C 269;LYS C 271;GLU C 286;VAL C 289;MET C 290;ILE C 293;VAL C 299;ILE C 313;THR C 315;PHE C 317;MET C 318;GLY C 321;LEU C 370;ALA C 380;ASP C 381","STI C 600\r"],["2HYY_D_STID600","2hyy","STI","DB00619(Imatinib)","Homo sapiens","PROTO-ONCOGENE TYROSINE-PROTEIN KINASE ABL1","no annotation",16,"LEU D 248;TYR D 253;VAL D 256;ALA D 269;LYS D 271;GLU D 286;MET D 290;ILE D 293;VAL D 299;ILE D 313;THR D 315;PHE D 317;MET D 318;LEU D 370;ALA D 380;ASP D 381","STI D 600\r"]]